CopperMeadow58
archive participant · first seen Jun 28, 2026 · last active Jul 22
2topics
24replies
0likes
0same experience
0best answers
replied
When using pens - Does anyone else have a drip or two after waiting 10 secs?
I tried forty units through a thirty-one-gauge five-millimeter needle and held it for twenty seconds. No drip afterward. The finer needle p…
Jul 22
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
Week of July 11-18: Both subjects continue daily 4 mg subcutaneous ARA-290 plus 4 mg KLOW and 1 mg BPC-157. BPC-157 site for Subject A is l…
Jul 18
replied
When using pens - Does anyone else have a drip or two after waiting 10 secs?
I split recent shots between 45 and 90 degrees and added fifteen extra seconds of hold time. No more drips at either angle. For short needl…
Jul 15
replied
SS-31 Dosing Sequencing Side Effects and Mitochondrial Repair Before MOTS-c
This thread and the range of suggested protocols is interesting. Everyone is different and both metabolism and lifestyle affect how this co…
Jul 14
replied
SS-31 Dosing Sequencing Side Effects and Mitochondrial Repair Before MOTS-c
My first message said I was not coming at you. Your choice on dosing. I did check the reference list. The question remains whether those en…
Jul 14
replied
SS-31 Dosing Sequencing Side Effects and Mitochondrial Repair Before MOTS-c
I would like more detail on those amounts. What studies or milligram-per-kilogram conversions are they based on? Not judging, just curious.
Jul 14
replied
When using pens - Does anyone else have a drip or two after waiting 10 secs?
I also keep a few regular syringes on hand because pens are handy but not perfect. This dripping only started recently even though my techn…
Jul 13
started a topic
When using pens - Does anyone else have a drip or two after waiting 10 secs?
We have used these pens for quite a while across a couple of versions. Lately I have seen one or sometimes two or three drops come out afte…
Jul 13
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
July 10 update: Both subjects completed two weeks of treatment, or nine days once incorrect-reconstitution days are removed. Subject A is o…
Jul 10
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
July 6 update: Subject A has continued to extend pain-free walks in recent days though exact times were not recorded. Subject B’s newly rec…
Jul 7
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
Subject B reacted only to the ARA and tolerated all other injections fine. No autoimmune history and ANA negative. The next update provides…
Jul 7
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
My next report comes on the sixth of July. For the third, subject A managed these walking times and distances until back discomfort started…
Jul 3
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
Thanks for sharing. How was it reconstituted?
Jul 3
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
Correct. Subject B’s pain came from the ten-times-strength PBS error. PBS at the proper strength would not cause pain. pH is critical. The …
Jul 2
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
July 1 update: Subject A increased walk time by twelve seconds without pain. Subject B showed no changes. Both subjects’ vials were tested …
Jul 2
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
It can be brought back. All of us are the human trials and sharing the data matters.
Jul 1
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
Thanks. If a section for logs exists it was missed. If not, how could one be started? First-hand tracked progress counts as real data. Many…
Jun 30
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
Hope progress is found with ARA. That is possible. Three things are being tested today and tomorrow: pH of both current vials, the vial rec…
Jun 30
replied
Disclosing Peptide Use to Doctors: Insurance Risks and Provider Responses
I think telling your PCP makes the most sense. They should know anything that might affect your health and keep an eye on labs. They can lo…
Jun 30
replied
ARA-290 Research Log – Two Subjects with Neuropathy and Chronic Pain
Although the plan was to use only one compound, both subjects added BPC-157 site injections and KLOW for their specific problem areas. June…
Jun 30
page 1 of 2Older →